TABLE 2

Parameters characterizing BS muscle cluster of contractions following different pharmacological treatments i.c.v. delivered

One-way analysis of variance followed by Student-Newman-Keuls test was used for intergroup comparisons. Raclopride- and spiperone-treated groups were not included in statistics.


Intracerebroventricular Treatment

Number of Clusters

Latency of First Cluster

Duration of Clusters

Intercluster Interval

Frequency of Bursts
s s−1
8-OH-DPAT (20 μg) +Saline 3.14 ± 0.26 433 ± 92* 17 ± 1 221 ± 38 0.58 ± 0.03
+WAY100635 (20 μg) 2.20 ± 0.37 628 ± 91* 19 ± 3 235 ± 41 0.48 ± 0.04
+Raclopride (40 μg) 1 568 14 0.51
+β-Cyclodextrin 0.5% 3.25 ± 0.63 722 ± 238 16 ± 3 315 ± 81
+Spiperone (10 μg) 0 0.63 ± 0.04
Quinelorane (20 μg)

6.38 ± 0.75
98 ± 24
19 ± 1
226 ± 33
0.61 ± 0.04
  • * Significant difference (p < 0.05) compared with quinelorane treatment.

  • Significant difference (p < 0.01) compared with quinelorane treatment.